ID

42822

Description

Randomized Phase III Study of Intensive Chemotherapy with or without Dasatinib (Sprycel(TM)) in Adult Patients with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)

Keywords

Versions (5)
  1. 3/5/15 3/5/15 -
  2. 3/9/15 3/9/15 -
  3. 4/23/15 4/23/15 -
  4. 12/15/15 12/15/15 -
  5. 9/17/21 9/17/21 -
Uploaded on

September 17, 2021

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Adverse Event AMLSG 21-13 DRKS00007189 NCT02013648 Akute myeloische Leukämie (AML)

English

Adverse Event AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

1 forms  
Adverse Event
Description

Adverse Event

Point in time
Description

Point in time

Data type

integer

Alias
UMLS CUI [1,1]
C1276413
UMLS CUI [1,2]
C2348792
If Maintenance: Month
Description

Maintenance Month

Data type

integer

Alias
UMLS CUI-1
C0481504
UMLS CUI-2
C0439231
Description of Adverse Event
Description

Description of Adverse Event

Data type

text

Alias
UMLS CUI [1]
C0877248
Adverse Event Term
Description

Adverse Event Term

Data type

text

Alias
UMLS CUI-1
C2826934
Serious Adverse Event
Description

Serious Adverse Event

Data type

boolean

Alias
UMLS CUI-1
C1519255
Grade of Adverse Event
Description

Grade of Adverse Event

Data type

integer

Alias
UMLS CUI-1
C2985911
Outcome
Description

Outcome

Data type

integer

Alias
UMLS CUI-1
C1705586
Treatment/Action taken
Description

Treatment/Action taken

Data type

text

Alias
UMLS CUI-1
C0087111
Adverse Event Start Date
Description

Adverse Event Start Date

Data type

date

Alias
UMLS CUI-1
C2697888
Adverse Event End Date
Description

Adverse Event End Date

Data type

date

Alias
UMLS CUI-1
C2697886
Adverse Event related to
Description

Adverse Event related to

Cytarabine
Description

Cytarabine

Data type

integer

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0010711
Daunorubicin
Description

Daunorubicin

Data type

integer

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0011015
Dasatinib
Description

Dasatinib

Data type

integer

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C1455147
Underlying Disease
Description

Underlying Disease

Data type

integer

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0277554
Concomitant medication
Description

Concomitant medication

Data type

integer

Alias
UMLS CUI [1]
C2347852
Other
Description

Other

Data type

integer

Alias
UMLS CUI [1]
C0205394
Signature
Description

Signature

Date
Description

Date

Data type

date

Alias
UMLS CUI-1
C0011008
Name of Investigator
Description

Name of Investigator

Data type

text

Alias
UMLS CUI-1
C0008961
Signature of investigator
Description

Signature of investigator

Data type

text

Alias
UMLS CUI-1
C2346576
Back to the top of the page

Similar models

Adverse Event AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Adverse Event
Item
Point in time
integer
C1276413 (UMLS CUI [1,1])
C2348792 (UMLS CUI [1,2])
Point in time
Code List
Point in time
CL Item
Diagnostic (0)
C0086143 (UMLS CUI-1)
CL Item
Induction I (1)
C3179010 (UMLS CUI-1)
CL Item
Induction II (optional) (2)
C3179010 (UMLS CUI-1)
CL Item
Consolid. I (3)
C3179017 (UMLS CUI-1)
CL Item
Consolid. II (4)
C3179017 (UMLS CUI-1)
CL Item
Consolid. III (5)
C3179017 (UMLS CUI-1)
CL Item
Consolid. IV (6)
C3179017 (UMLS CUI-1)
CL Item
Maintenance (7)
C0481504 (UMLS CUI-1)
Item
If Maintenance: Month
integer
C0481504 (UMLS CUI-1)
C0439231 (UMLS CUI-2)
Maintenance Month
Code List
If Maintenance: Month
CL Item
after 1 Month (1)
C0439231 (UMLS CUI-1)
C0205447 (UMLS CUI-2)
CL Item
after 2 Months (2)
C0439231 (UMLS CUI-1)
C0205448 (UMLS CUI-2)
CL Item
after 3 Months (3)
C0439231 (UMLS CUI-1)
C0205449 (UMLS CUI-2)
CL Item
after 4 Months (4)
C0439231 (UMLS CUI-1)
C0205450 (UMLS CUI-2)
CL Item
after 5 Months (5)
C0439231 (UMLS CUI-1)
C0205451 (UMLS CUI-2)
CL Item
after 6 Months (6)
C0439231 (UMLS CUI-1)
C0205452 (UMLS CUI-2)
CL Item
after 7 Months (7)
C0439231 (UMLS CUI-1)
C0205453 (UMLS CUI-2)
CL Item
after 8 Months (8)
C0439231 (UMLS CUI-1)
C0205454 (UMLS CUI-2)
CL Item
after 9Months (9)
C0439231 (UMLS CUI-1)
C0205455 (UMLS CUI-2)
CL Item
after 10 Months (10)
C0439231 (UMLS CUI-1)
C0205456 (UMLS CUI-2)
CL Item
after 11 Months (11)
C0439231 (UMLS CUI-1)
C0205457 (UMLS CUI-2)
CL Item
after 12 Months (12)
C0439231 (UMLS CUI-1)
C0205458 (UMLS CUI-2)
Description of Adverse Event
Item
Description of Adverse Event
text
C0877248 (UMLS CUI [1])
Adverse Event Term
Item
Adverse Event Term
text
C2826934 (UMLS CUI-1)
Serious Adverse Event
Item
Serious Adverse Event
boolean
C1519255 (UMLS CUI-1)
Item
Grade of Adverse Event
integer
C2985911 (UMLS CUI-1)
Grade of Adverse Event
Code List
Grade of Adverse Event
CL Item
Mild  (1)
C2945599 (UMLS CUI-1)
CL Item
Moderate (2)
C0205081 (UMLS CUI-1)
CL Item
Severe (3)
C0205082 (UMLS CUI-1)
CL Item
Life-Threatening (4)
C2826244 (UMLS CUI-1)
CL Item
Death related to AE (5)
C0877248 (UMLS CUI-1)
C0011065 (UMLS CUI-2)
Item
Outcome
integer
C1705586 (UMLS CUI-1)
Outcome
Code List
Outcome
CL Item
recovered (1)
C2826210 (UMLS CUI-1)
CL Item
not yet recovered (2)
C1709277 (UMLS CUI-1)
CL Item
recovered with sequelae (3)
C1709862 (UMLS CUI-1)
CL Item
Death (4)
C0011065 (UMLS CUI-1)
CL Item
unknown (5)
C0439673 (UMLS CUI-1)
Treatment/Action taken
Item
Treatment/Action taken
text
C0087111 (UMLS CUI-1)
Adverse Event Start Date
Item
Adverse Event Start Date
date
C2697888 (UMLS CUI-1)
Adverse Event End Date
Item
Adverse Event End Date
date
C2697886 (UMLS CUI-1)
Item Group
Adverse Event related to
Item
Cytarabine
integer
C0877248 (UMLS CUI [1,1])
C0010711 (UMLS CUI [1,2])
Cytarabine
Code List
Cytarabine
CL Item
definitely (1)
C1704787 (UMLS CUI-1)
CL Item
probably (2)
C0750492 (UMLS CUI-1)
CL Item
possible (3)
C0332149 (UMLS CUI-1)
CL Item
unlikely (4)
C0750558 (UMLS CUI-1)
CL Item
not related (5)
C1546988 (UMLS CUI-1)
CL Item
Medication not administered (6)
C0445106 (UMLS CUI-1)
C0806914 (UMLS CUI-2)
Item
Daunorubicin
integer
C0877248 (UMLS CUI [1,1])
C0011015 (UMLS CUI [1,2])
Cytarabine
Code List
Daunorubicin
CL Item
definitely (1)
C1704787 (UMLS CUI-1)
CL Item
probably (2)
C0750492 (UMLS CUI-1)
CL Item
possible (3)
C0332149 (UMLS CUI-1)
CL Item
unlikely (4)
C0750558 (UMLS CUI-1)
CL Item
not related (5)
C1546988 (UMLS CUI-1)
CL Item
Medication not administered (6)
C0445106 (UMLS CUI-1)
C0806914 (UMLS CUI-2)
Item
Dasatinib
integer
C0877248 (UMLS CUI [1,1])
C1455147 (UMLS CUI [1,2])
Cytarabine
Code List
Dasatinib
CL Item
definitely (1)
C1704787 (UMLS CUI-1)
CL Item
probably (2)
C0750492 (UMLS CUI-1)
CL Item
possible (3)
C0332149 (UMLS CUI-1)
CL Item
unlikely (4)
C0750558 (UMLS CUI-1)
CL Item
not related (5)
C1546988 (UMLS CUI-1)
CL Item
Medication not administered (6)
C0445106 (UMLS CUI-1)
C0806914 (UMLS CUI-2)
Item
Underlying Disease
integer
C0877248 (UMLS CUI [1,1])
C0277554 (UMLS CUI [1,2])
Outcome
Code List
Underlying Disease
CL Item
recovered (1)
C2826210 (UMLS CUI-1)
CL Item
not yet recovered (2)
C1709277 (UMLS CUI-1)
CL Item
recovered with sequelae (3)
C1709862 (UMLS CUI-1)
CL Item
Death (4)
C0011065 (UMLS CUI-1)
CL Item
unknown (5)
C0439673 (UMLS CUI-1)
Item
Concomitant medication
integer
C2347852 (UMLS CUI [1])
Cytarabine
Code List
Concomitant medication
CL Item
definitely (1)
C1704787 (UMLS CUI-1)
CL Item
probably (2)
C0750492 (UMLS CUI-1)
CL Item
possible (3)
C0332149 (UMLS CUI-1)
CL Item
unlikely (4)
C0750558 (UMLS CUI-1)
CL Item
not related (5)
C1546988 (UMLS CUI-1)
CL Item
Medication not administered (6)
C0445106 (UMLS CUI-1)
C0806914 (UMLS CUI-2)
Item
Other
integer
C0205394 (UMLS CUI [1])
Outcome
Code List
Other
CL Item
recovered (1)
C2826210 (UMLS CUI-1)
CL Item
not yet recovered (2)
C1709277 (UMLS CUI-1)
CL Item
recovered with sequelae (3)
C1709862 (UMLS CUI-1)
CL Item
Death (4)
C0011065 (UMLS CUI-1)
CL Item
unknown (5)
C0439673 (UMLS CUI-1)
Item Group
Signature
Date
Item
Date
date
C0011008 (UMLS CUI-1)
Name of Investigator
Item
Name of Investigator
text
C0008961 (UMLS CUI-1)
Signature of investigator
Item
Signature of investigator
text
C2346576 (UMLS CUI-1)
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial